Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 2/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | IDH2 | P48735 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.32 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.32 |
| ▸ | KMO | O15229 | 1/20 | 0.31 |
| ▸ | NNMT | P40261 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8324406 | 0.84 | KMO (0.33) | AKR1C3AKR1C2KMO | |
| SCHEMBL875750 | 0.79 | KDM5A (0.33) | KDM5A | |
| SCHEMBL8548569 | 0.75 | ACP3 (0.36) | CYP2C19P2RX7KMO | |
| SCHEMBL8328817 | 0.74 | — | — | |
| SCHEMBL5030111 | 0.71 | PIK3CD (0.34) | CYP2C19P2RX7KMO | |
| SCHEMBL9027404 | 0.70 | P2RX7 (0.31) | P2RX7KMO | |
| SCHEMBL364870 | 0.70 | P2RX7 (0.36) | P2RX7KMO | |
| SCHEMBL4595530 | 0.70 | ULK1 (0.34) | P2RX7AKR1C3AKR1C2 | |
| SCHEMBL29460067 | 0.69 | PIK3CD (0.35) | KMOADRB2 | |
| SCHEMBL1961605 | 0.69 | PIK3CD (0.35) | KMOADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050239656-A1 | Pyridine compounds or salts thereof and herbicides containing the same | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1500650-A1 | PYRIDINE COMPOUNDS OR SALTS THEREOF AND HERBICIDES CONTAINING THE SAME | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239656-A1 | Pyridine compounds or salts thereof and herbicides containing the same | CBR3, CYP2C8, ABCC8 | PDE2A 2642/4885CYP17A1 919/4885CYP2C9 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.